JNJ director granted deferred share units

HEWSON MARILLYN A reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

HEWSON MARILLYN A reported acquisition or exercise transactions in this Form 4 filing.

Johnson & Johnson director Marillyn A. Hewson reported receiving 214.786 Deferred Share Units on June 9, 2026 as a grant under the company’s Amended and Restated Deferred Fee Plan for Directors. These units represent deferred cash retainers and are to be settled in cash when her board service ends, bringing her total Deferred Share Units to 15,791.877, including amounts accrued as dividend equivalent rights.

Insider Trade Summary

Grant/Award: 214.786 shares

Grant/Award 1 txn

Insider HEWSON MARILLYN A

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Deferred Share Units	214.786	$232.79	$50K

Holdings After Transaction: Deferred Share Units — 15,791.877 contracts (Direct)

Footnotes (2)

1. F1. Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.
2. F2. Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.

Key Figures

Deferred Share Units granted: 214.786 units Reference value per unit: $232.79 per unit Total Deferred Share Units after grant: 15,791.877 units +2 more

5 metrics

Deferred Share Units granted 214.786 units Grant/award acquisition on June 9, 2026

Reference value per unit $232.79 per unit Fair market value basis for new Deferred Share Units

Total Deferred Share Units after grant 15,791.877 units Holdings following the June 9, 2026 transaction

Underlying common stock equivalent 214.786 shares Each Deferred Share Unit tracks one common stock equivalent

Conversion/exercise price $0.00 Deferred Share Units settled in cash, no exercise price

Key Terms

Deferred Share Units, Amended and Restated Deferred Fee Plan for Directors, dividend equivalent rights

3 terms

Deferred Share Units financial

"Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors."

Deferred share units are promises that give an executive or director the right to receive company shares or their cash value at a future date, often when they retire or leave the company. Think of them as a paycheck held in a savings account that converts into stock later; they matter to investors because they tie pay to long-term performance, create potential future dilution of shares, and represent a delayed cash or share obligation the company must eventually fulfill.

Amended and Restated Deferred Fee Plan for Directors financial

"Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors."

dividend equivalent rights financial

"Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person."

Dividend equivalent rights are promises that mirror the cash payments shareholders get from a company’s profits, but they are paid to holders of certain awards (like stock options or restricted stock units) rather than to actual shares. Think of them as a paycheck top‑up that matches dividends while the award is not yet a real stock, and they matter to investors because they add to employee compensation costs and potential share dilution, affecting company profitability and per‑share value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Marillyn A. Hewson report for Johnson & Johnson (JNJ)?

Marillyn A. Hewson reported acquiring 214.786 Deferred Share Units for Johnson & Johnson on June 9, 2026. The grant reflects deferral of her cash retainer under the director fee plan and increases her total Deferred Share Units to 15,791.877, including dividend-equivalent accruals.

Are Marillyn A. Hewson’s Johnson & Johnson Deferred Share Units settled in stock or cash?

Hewson’s Deferred Share Units are settled in cash, not stock. Each unit represents the fair market value of one Johnson & Johnson common share on the business day before settlement and will be paid in cash when her directorship with the company terminates under the deferred fee plan.

How many Johnson & Johnson Deferred Share Units does Marillyn A. Hewson hold after this Form 4?

After this transaction, Hewson holds a total of 15,791.877 Deferred Share Units linked to Johnson & Johnson. This total includes the newly awarded 214.786 units and additional units credited as dividend equivalent rights connected to the company’s regular quarterly dividend on previously held units.

What price per unit is associated with Marillyn A. Hewson’s new Deferred Share Units at Johnson & Johnson?

The 214.786 Deferred Share Units granted to Hewson are associated with a reference value of $232.79 per unit. Each unit tracks the fair market value of a Johnson & Johnson common share and will ultimately be settled in cash when her board service with the company ends.

What plan governs Marillyn A. Hewson’s Deferred Share Units at Johnson & Johnson (JNJ)?

Hewson’s Deferred Share Units are issued under Johnson & Johnson’s Amended and Restated Deferred Fee Plan for Directors. The grant reflects deferral of her cash retainer into units that mirror the company’s share value and accumulate dividend equivalent rights until cash settlement at directorship termination.

Do Marillyn A. Hewson’s Deferred Share Units at Johnson & Johnson earn dividend equivalents?

Yes. Her Deferred Share Units include dividend equivalent rights tied to Johnson & Johnson’s quarterly dividend. Additional units accrue over time based on dividends on units she already holds, and these dividend-related units are included in the reported total of 15,791.877 Deferred Share Units.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/11/2026 - 04:35 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

HEWSON MARILLYN A

(Last) (First) (Middle)

ONE JOHNSON & JOHNSON PLAZA

(Street)

NEW BRUNSWICK NEW JERSEY 08933

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
JOHNSON & JOHNSON [ JNJ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/09/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Share Units	(1)	06/09/2026		A		214.786		(1)	(1)	Common Stock	214.786	$232.79	15,791.877(2)	D

Explanation of Responses:

1. Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.

2. Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.

Remarks:

	/s/ Joleen Morgan, as attorney-in-fact for Marillyn A. Hewson	06/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)